On October 19, 2018, the board of directors of Kindred Biosciences, Inc. appointed Denise Bevers, Co-Founder and Chief Operating Officer of KindredBio, to serve as President and Class III director of the company, effective as of October 19, 2018, for a term expiring at the 2019 annual meeting of stockholders. In her expanded role as President, Ms. Bevers will be responsible for all operational functions. She will retain her title as COO and continue to oversee the commercial organization, including the launch of KindredBio's first product, Mirataz. Prior to co-founding KindredBio, she was President and Founding Partner of SD Scientific. Denise M. Bevers is one of the Company's co-founders and has served as Chief Operating Officer since October 2012. On November 11, 2013, she was appointed as Secretary. She has over 20 years of human pharmaceutical and research experience and is an expert in clinical operations, medical affairs, and scientific communications.